954 — Changmao Biochemical Engineering Co Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$248.96m
- HK$759.22m
- CNY637.08m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 62.6 | 17.2 | 84.4 | 87.6 | -58.6 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 0.623 | 14.9 | -86.9 | 29.2 | 61.5 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 19.8 | -5.89 | -33.7 | -129 | -46 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 118 | 58.9 | -6.94 | 19.6 | -2.35 |
Capital Expenditures | -41.3 | -79.1 | -252 | -224 | -139 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 5.48 | 86.3 | 107 | 2.81 | 17.1 |
Sale of Fixed Assets | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -35.8 | 7.15 | -145 | -221 | -122 |
Financing Cash Flow Items | — | — | — | -0.66 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -45.2 | -49.8 | 76.7 | 200 | 154 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 37.9 | 14.4 | -75.5 | 1.81 | 29.6 |